(Q44887004)

7 December 2017

title

Hyperhomocysteinemia in patients with diabetes mellitus with and without diabetic retinopathy (English)

1 reference

7 December 2017

Goldstein M

1

1 reference

7 December 2017

Leibovitch I

2

1 reference

7 December 2017

Yeffimov I

3

1 reference

7 December 2017

Gavendo S

4

1 reference

7 December 2017

Sela BA

5

1 reference

7 December 2017

Loewenstein A

6

1 reference

7 December 2017

publication date

1 May 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

18

1 reference

7 December 2017

issue

5

1 reference

7 December 2017

page(s)

460-465

1 reference

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Hyperhomocysteinaemia in young patients with non-arteritic anterior ischaemic optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Homocysteine and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Effects of fenofibrate and gemfibrozil on plasma homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Retinopathy in juvenile-onset type I diabetes of short duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Effect of pregnancy on progression of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Biological variability and reference intervals for total plasma homocysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Hyperhomocysteinemia Is Associated With the Presence of Retinopathy in Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

Hyperhomocysteinemia: an independent risk factor for vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Serum total homocysteine and coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Retinal vein occlusion and transient monocular visual loss associated with hyperhomocystinemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Bilateral retinal vein occlusion associated with 5,10-methylenetetrahydrofolate reductase mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Ocular venous occlusion and hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Hyperhomocysteinemia: a risk factor for central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Hyperhomocysteinemia in retinal artery and retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Homocystinemia. Vascular injury and arterial thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Remethylation defects: guidelines for clinical diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Serum homocysteine increases after therapy with fenofibrate or bezafibrate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

The Natural History of Retinopathy in Insulin-Dependent Juvenile-Onset Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Retinopathy in young-onset diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Effect of consumption of red wine, spirits, and beer on serum homocysteine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Hypoxic regulation of vascular endothelial growth factor in retinal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700702

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6700702

1 reference

7 December 2017

1 reference